Zhitong Finance App News, Kehua Biotech (002022.SZ) issued an announcement. Recently, Suzhou Tianlong Biotechnology Co., Ltd., the company's holding subsidiary, received a medical device registration certificate (in vitro diagnostic reagent) issued by the State Drug Administration. The product is: “Norovirus GI and GII nucleic acid typing kit (fluorescence PCR method)”. This kit is used to qualitatively test norovirus type GI and GII nucleic acid RNA in fecal samples in vitro.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.